Literature DB >> 11935348

Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPR.

Peter P Schmidt1, Kim G Toft, Tore Skotland, KristofferK Andersson.   

Abstract

MnDPDP [manganese(II) N, N'-dipyridoxylethylenediamine- N, N'-diacetate-5,5'-bis(phosphate)] is the active component of Teslascan, a contrast medium for magnetic resonance imaging of the liver. It has previously been shown that MnDPDP is rapidly dephosphorylated to the monophosphate MnDPMP and the non-phosphorylated MnPLED, and that all these substances are rapidly transmetallated to the corresponding Zn complexes. In the present study we used EPR at 9 and 230 GHz to show that no free Mn(2+) ions can be detected in the product or in a mixture of MnDPDP and human serum. Competition experiments between MnDPDP and Zn(2+), Ca(2+), and Mg(2+) ions revealed approximately 15% transmetallation with Zn(2+) in a buffer system containing metal ion concentrations similar to that in serum, whereas approximately 10% transmetallation was obtained with Ca(2+) and only negligible transmetallation was obtained with Mg(2+) under these conditions. Binding experiments with Mn(2+) added to human albumin and human serum indicate that albumin accounts for most of the protein-bound Mn(2+) in serum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11935348     DOI: 10.1007/s007750100290

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  10 in total

1.  Manganese displacement from Zinpyr-1 allows zinc detection by fluorescence microscopy and magnetic resonance imaging.

Authors:  Youngmin You; Elisa Tomat; Kevin Hwang; Tatjana Atanasijevic; Wonwoo Nam; Alan P Jasanoff; Stephen J Lippard
Journal:  Chem Commun (Camb)       Date:  2010-05-10       Impact factor: 6.222

Review 2.  Manganese toxicity upon overexposure.

Authors:  Janelle Crossgrove; Wei Zheng
Journal:  NMR Biomed       Date:  2004-12       Impact factor: 4.044

3.  Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI.

Authors:  Margaret F Bennewitz; Tricia L Lobo; Michael K Nkansah; Gözde Ulas; Gary W Brudvig; Erik M Shapiro
Journal:  ACS Nano       Date:  2011-05-03       Impact factor: 15.881

Review 4.  Synthetic approaches to heterocyclic ligands for Gd-based MRI contrast agents.

Authors:  Elena Pérez-Mayoral; Jordi Soler-Padrós; Viviana Negri; Sebastián Cerdán; Paloma Ballesteros
Journal:  Molecules       Date:  2007-08-09       Impact factor: 4.411

5.  Novel biscapped and monocapped tris(dioxime) Mn(II) complexes: x-ray crystal structure of the first cationic tris(dioxime) Mn(II) complex [Mn(CDOH)3BPh]OH (CDOH2= 1,2-cyclohexanedione dioxime).

Authors:  Wen-Yuan Hsieh; Shuang Liu
Journal:  Inorg Chem       Date:  2006-06-26       Impact factor: 5.165

Review 6.  MR imaging probes: design and applications.

Authors:  Eszter Boros; Eric M Gale; Peter Caravan
Journal:  Dalton Trans       Date:  2015-03-21       Impact factor: 4.390

7.  Superior therapeutic index of calmangafodipir in comparison to mangafodipir as a chemotherapy adjunct.

Authors:  Jan Olof G Karlsson; Tino Kurz; Susanne Flechsig; Jacques Näsström; Rolf Gg Andersson
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

8.  Toward clinical application of manganese-enhanced MRI of retinal function.

Authors:  Paul S Tofts; Andre Porchia; Ying Jin; Robin Roberts; Bruce A Berkowitz
Journal:  Brain Res Bull       Date:  2009-06-11       Impact factor: 4.077

9.  Manganese-Enhanced MRI of the Brain in Healthy Volunteers.

Authors:  D M Sudarshana; G Nair; J T Dwyer; B Dewey; S U Steele; D J Suto; T Wu; B A Berkowitz; A P Koretsky; I C M Cortese; D S Reich
Journal:  AJNR Am J Neuroradiol       Date:  2019-08-01       Impact factor: 3.825

Review 10.  MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue.

Authors:  Per Jynge; Arne M Skjold; Ursula Falkmer; Rolf G G Andersson; John G Seland; Morten Bruvold; Viggo Blomlie; Willy Eidsaunet; Jan O G Karlsson
Journal:  Contrast Media Mol Imaging       Date:  2020-09-04       Impact factor: 3.161

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.